DM1 protein kinase
Última atualização 10 Apr 2023
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
A DMPK gene provides instructions for making a protein called myotonic dystrophy protein kinase. This protein appears to play an important role in muscle, heart, and brain cells. The protein may be involved in communication within cells. It also appears to regulate the production and function of important structures inside muscle cells by interacting with other proteins. For example, myotonic dystrophy protein kinase has been shown to turn off (inhibit) part of a muscle protein called myosin phosphatase. Myosin phosphatase is an enzyme that plays a role in muscle tensing (contraction) and relaxation.
Escolhas de vídeos para GenesBiblioteca de vídeos
Normal function
A DMPK gene provides instructions for making a protein called myotonic dystrophy protein kinase. This protein appears to play an important role in muscle, heart, and brain cells. The protein may be involved in communication within cells. It also appears to regulate the production and function of important structures inside muscle cells by interacting with other proteins. For example, myotonic dystrophy protein kinase has been shown to turn off (inhibit) part of a muscle protein called myosin phosphatase. Myosin phosphatase is an enzyme that plays a role in muscle tensing (contraction) and relaxation.
One region of the DMPK gene contains a segment of three DNA building blocks (nucleotides) that is repeated multiple times. This sequence, which is written as CTG, is called a triplet or trinucleotide repeat. In most people, the number of CTG repeats in this gene ranges from 5 to 34.
Conditions referring to this gene or chromosome
Other names
DM protein kinase
DM-kinase
DM-PK
DM1
Dm15
DM1PK
DMK
DMPK_HUMAN
dystrophia myotonica 1
dystrophia myotonica kinase, B15
dystrophia myotonica protein kinase
dystrophia myotonica-protein kinase
MDPK
MT-PK
myotonic dystrophy protein kinase
myotonin
myotonin-protein kinase
Related patient information and medicines

Patient information leaflet
Distrofia muscular de Duchenne
How common is Duchenne muscular dystrophy. About 1 in 3,500 boys in the UK are born with DMD. Duchenne muscular dystrophy is caused by a genetic change which affects the muscles. Muscles contain a protein called dystrophin, which is necessary for muscles to function properly. ... One of these proteins is the dystrophin protein which is involved in.

Patient information leaflet
Distrofia muscular
Muscular dystrophy cannot be cured but there are various treatments which can help. Muscular dystrophy (MD) is the name given to a group of disorders which cause progressive muscle weakness (meaning it gets worse over time). Also, if a ch... MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase.

Patient information leaflet
Distúrbios de armazenamento de glicogênio
Distúrbios de armazenamento de glicogênio are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. Glycogen storage disorders are a group of inherited diseases that result from a lack of, or abnormal functioning of,.

Patient information leaflet
Artrite idiopática juvenil
The inflammation causes swelling around the affected joints. So, juvenile idiopathic arthritis (JIA) is a condition in which this inflammation of one or more joints begins in children under the age of 16 years. It lasts for at least six weeks. Options include: Etanercept Etanercept Tocilizumab Infliximab Abatacept Adalimumab Tofacitinib is another.

Patient information leaflet
Câncer primário de fígado
Over the last few years, public health campaigns encouraging testing have. However, these are common infections worldwide, particularly in Asia and Africa. It is not likely to be curative for p... There are new medicines being developed for the treatment of liver cancer. For example, sorafenib is a type of medicine called a multi-targeted kinase.

Patient information leaflet
Testes de função hepática
Fígado function tests are also used for monitoring in cases of known liver inflammation, injury or disease. What are the main liver function tests. Gamma GT. Creatina quinase. Prothrombin time or International Normali... Low levels of total protein can sometimes be seen in severe liver disease, in conditions of severe protein loss (such as.
Leitura adicional e referências
- DM1 protein kinase; MedlinePlus, National Library of Medicine.
- Bird TD. Myotonic Dystrophy Type 1. 1999 Sep 17 [updated 2024 Nov 14]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1165/
- Botta A, Rinaldi F, Catalli C, Vergani L, Bonifazi E, Romeo V, Loro E, Viola A, Angelini C, Novelli G. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients. J Med Genet. 2008 Oct;45(10):639-46. doi: 10.1136/jmg.2008.058909. Epub 2008 Jul 8.
- Cho DH, Tapscott SJ. Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta. 2007 Feb;1772(2):195-204. doi: 10.1016/j.bbadis.2006.05.013. Epub 2006 Jun 20.
- Kaliman P, Llagostera E. Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1. Cell Signal. 2008 Nov;20(11):1935-41. doi: 10.1016/j.cellsig.2008.05.005. Epub 2008 May 18.
- Overend G, Legare C, Mathieu J, Bouchard L, Gagnon C, Monckton DG. Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes. Hum Mol Genet. 2019 Jul 1;28(13):2245-2254. doi: 10.1093/hmg/ddz055.
- Ranum LP, Day JW. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet. 2004 May;74(5):793-804. doi: 10.1086/383590. Epub 2004 Apr 2.
- Salvatori S, Fanin M, Trevisan CP, Furlan S, Reddy S, Nagy JI, Angelini C. Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1. Neurol Sci. 2005 Oct;26(4):235-42. doi: 10.1007/s10072-005-0466-x.
- Santoro M, Masciullo M, Silvestri G, Novelli G, Botta A. Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis. Clin Genet. 2017 Oct;92(4):355-364. doi: 10.1111/cge.12954. Epub 2017 Feb 22.
- Ueda H, Ohno S, Kobayashi T. Myotonic dystrophy and myotonic dystrophy protein kinase. Prog Histochem Cytochem. 2000;35(3):187-251. doi: 10.1016/s0079-6336(00)80002-9.
Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.
Inscreva-se no boletim informativo do Patient
Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.

